BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27547861)

  • 1. Cost-Effectiveness of Tomosynthesis in Annual Screening Mammography.
    Kalra VB; Wu X; Haas BM; Forman HP; Philpotts LE
    AJR Am J Roentgenol; 2016 Nov; 207(5):1152-1155. PubMed ID: 27547861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts.
    Lee CI; Cevik M; Alagoz O; Sprague BL; Tosteson AN; Miglioretti DL; Kerlikowske K; Stout NK; Jarvik JG; Ramsey SD; Lehman CD
    Radiology; 2015 Mar; 274(3):772-80. PubMed ID: 25350548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Screening Mammography: Performance of Full-Field Digital Mammography Versus Digital Breast Tomosynthesis.
    McDonald ES; McCarthy AM; Akhtar AL; Synnestvedt MB; Schnall M; Conant EF
    AJR Am J Roentgenol; 2015 Nov; 205(5):1143-8. PubMed ID: 26496565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening.
    Haas BM; Kalra V; Geisel J; Raghu M; Durand M; Philpotts LE
    Radiology; 2013 Dec; 269(3):694-700. PubMed ID: 23901124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis.
    Sankatsing VDV; Juraniec K; Grimm SE; Joore MA; Pijnappel RM; de Koning HJ; van Ravesteyn NT
    Radiology; 2020 Oct; 297(1):40-48. PubMed ID: 32749212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
    Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
    Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical experience with digital breast tomosynthesis for screening mammography.
    Durand MA; Haas BM; Yao X; Geisel JL; Raghu M; Hooley RJ; Horvath LJ; Philpotts LE
    Radiology; 2015 Jan; 274(1):85-92. PubMed ID: 25188431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
    Lee JM; McMahon PM; Kong CY; Kopans DB; Ryan PD; Ozanne EM; Halpern EF; Gazelle GS
    Radiology; 2010 Mar; 254(3):793-800. PubMed ID: 20177093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tomosynthesis Impact on Breast Cancer Screening in Patients Younger Than 50 Years Old.
    Rose SL; Shisler JL
    AJR Am J Roentgenol; 2018 Jun; 210(6):1401-1404. PubMed ID: 29629810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
    JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography.
    Rafferty EA; Rose SL; Miller DP; Durand MA; Conant EF; Copit DS; Friedewald SM; Plecha DM; Ott IL; Hayes MK; Carlson KL; Cink TM; Barke LD; Greer LN; Niklason LT
    Breast Cancer Res Treat; 2017 Aug; 164(3):659-666. PubMed ID: 28523569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening using tomosynthesis in combination with digital mammography.
    Friedewald SM; Rafferty EA; Rose SL; Durand MA; Plecha DM; Greenberg JS; Hayes MK; Copit DS; Carlson KL; Cink TM; Barke LD; Greer LN; Miller DP; Conant EF
    JAMA; 2014 Jun; 311(24):2499-507. PubMed ID: 25058084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice.
    Greenberg JS; Javitt MC; Katzen J; Michael S; Holland AE
    AJR Am J Roentgenol; 2014 Sep; 203(3):687-93. PubMed ID: 24918774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
    Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
    BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total cost-effectiveness of mammography screening strategies.
    Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
    Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis.
    Cressman S; Mar C; Sam J; Kan L; Lohrisch C; Spinelli JJ
    CMAJ Open; 2021; 9(2):E443-E450. PubMed ID: 33888549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
    Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
    Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.